20:50 , Oct 10, 2017 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: SNPs A SNP on the GPX3 - Tnip1 locus could help predict the risk of ALS. Genome-wide association studies in 13,811 ALS patients and 26,325 healthy volunteers identified an association between the disease and...
07:00 , Sep 26, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Huntington's disease Glutathione peroxidase 1 (GPX1); glutathione peroxidase 3 plasma (GPX3) Yeast and fly studies suggest glutathione peroxidase mimics could be...
07:00 , Apr 26, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Glutathione peroxidase 3 plasma (GPX3); tumor protein p53 inducible protein 3 (TP53I3; PIG3) In vitro studies suggest increasing the...
07:00 , Apr 9, 2009 |  BC Innovations  |  Cover Story

Opening up Rosetta

Merck & Co. Inc. 's soon-to-be shuttered Rosetta Inpharmatics Inc. unit is to be reborn as Sage , a not-for-profit institute that aims to provide precompetitive open access to the pharma's integrative genomics data set....
07:00 , Apr 9, 2009 |  BC Innovations  |  Distillery Therapeutics

This week in therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Metabolic disease Obesity Component 3a receptor 1 (C3AR1); transforming growth factor-b receptor II (TGFBR2); growth arrest-specific gene 7 (GAS7); glutathione peroxidase...